Related references
Note: Only part of the references are listed.Functional polymorphisms of folate metabolism and response to chemotherapy for colorectal cancer, a systematic review and meta-analysis
Barbara Anne Jennings et al.
PHARMACOGENETICS AND GENOMICS (2012)
Molecular approaches to personalizing management of ovarian cancer
R. C. Bast
ANNALS OF ONCOLOGY (2011)
Considering Early Detection of Relapsed Ovarian Cancer A Review of the Literature
Sandra M. E. Geurts et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2011)
Recurrent Ovarian Cancer: When and How to Treat
Marcia Hall et al.
CURRENT ONCOLOGY REPORTS (2011)
Relationship between the expression of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase and survival in epithelial ovarian cancer
Changyu Wang et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2010)
Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
M. Gusella et al.
BRITISH JOURNAL OF CANCER (2009)
K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy
Marie-Christine Etienne-Grimaldi et al.
CLINICAL CANCER RESEARCH (2008)
Thymidylate synthase genotyping is more predictive for therapy response than immunohistochemistry in patients with colon cancer
Marleen I. Gosens et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer
Georg Lurje et al.
PHARMACOGENETICS AND GENOMICS (2008)
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
A. Ruzzo et al.
PHARMACOGENOMICS JOURNAL (2008)
Differential stability of thymidylate synthase 3′-untranslated region polymorphic variants regulated by AUF1
Rudolf Pullmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil
E Hitre et al.
PHARMACOGENETICS AND GENOMICS (2005)
A common insertion/deletion polymorphism of the thymidylate synthase (TYMS) gene is a determinant of red blood cell folate and homocysteine concentrations
C Kealey et al.
HUMAN GENETICS (2005)
Thymidylate synthase as an oncogene: A novel role for an essential DNA synthesis enzyme
L Rahman et al.
CANCER CELL (2004)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma
CF Skibola et al.
BLOOD (2004)
A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels
MV Mandola et al.
PHARMACOGENETICS (2004)
New prognostic indicator for non-small-cell lung cancer, quantitation of thymidylate synthase by real-time reverse transcription polymerase chain reaction
Y Shintani et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Clinical significance of thymidylate synthase expression in bladder cancer
T Nomura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2002)
Predictive and prognostic markers in gastrointestinal cancers
CG Leichman
CURRENT OPINION IN ONCOLOGY (2001)
Share Paper
